Literature DB >> 9533029

Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma.

S Bekri1, J Adélaïde, S Merscher, J Grosgeorge, F Caroli-Bosc, D Perucca-Lostanlen, P M Kelley, M J Pébusque, C Theillet, D Birnbaum, P Gaudray.   

Abstract

Amplification of loci present on band q13 of human chromosome 11 is a feature of a subset of estrogen receptor positive breast carcinomas prone to metastasis. As many as five distinct amplification units have been described on 11q13. They include particularly a genomic area encompassing the GARP gene at 11q13.5-->q14.1. We have reassessed our current knowledge of this region, located telomeric to CCND1 and EMS1, which is amplified in 7-10% of mammary tumors. The loose definition of the driving forces of these amplification events led us to map accurately the boundaries of the amplifiable region, and thus to contribute a physical and transcriptional map of a 3-Mb region of chromosome 11. Four new genes were placed on the regional map, namely CBP2, CLNS1A, UVRAG, and PAK1. We have narrowed the core of the 11q13-->q14 amplicon to a 350-kb area encompassing D11S533, mostly on its telomeric side. The map reported here represents an indispensable step toward sequencing the entire region, and thus toward uncovering gene(s) which play(s) a critical role in breast cancer progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9533029     DOI: 10.1159/000134699

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  47 in total

Review 1.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

2.  Beyond autophagy: the role of UVRAG in membrane trafficking.

Authors:  Chengyu Liang; Donna Sir; Steven Lee; Jing-Hsiung James Ou; Jae U Jung
Journal:  Autophagy       Date:  2008-06-25       Impact factor: 16.016

Review 3.  Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.

Authors:  Richard Marcotte; William J Muller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-24       Impact factor: 2.673

4.  Src tyrosyl phosphorylates cortactin in response to prolactin.

Authors:  Alan Hammer; Sneha Laghate; Maria Diakonova
Journal:  Biochem Biophys Res Commun       Date:  2015-06-01       Impact factor: 3.575

5.  Expression of EMSY gene in sporadic ovarian cancer.

Authors:  Julide Altinisik; Ates Karateke; Hakan Coksuer; Turgut Ulutin; Nur Buyru
Journal:  Mol Biol Rep       Date:  2010-03-28       Impact factor: 2.316

Review 6.  GAB2--a scaffolding protein in cancer.

Authors:  Sarah J Adams; Iraz T Aydin; Julide T Celebi
Journal:  Mol Cancer Res       Date:  2012-08-07       Impact factor: 5.852

7.  UVRAG is required for organ rotation by regulating Notch endocytosis in Drosophila.

Authors:  Gina Lee; Chengyu Liang; Gihyun Park; Cholsoon Jang; Jae U Jung; Jongkyeong Chung
Journal:  Dev Biol       Date:  2011-06-25       Impact factor: 3.582

8.  High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells.

Authors:  Xin Huang; Susanne M Gollin; Siva Raja; Tony E Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

9.  Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.

Authors:  Peter Schraml; Georg Schwerdtfeger; Felix Burkhalter; Anna Raggi; Dietmar Schmidt; Teresa Ruffalo; Walter King; Kim Wilber; Michael J Mihatsch; Holger Moch
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.

Authors:  S S Kwek; R Roy; H Zhou; J Climent; J A Martinez-Climent; J Fridlyand; D G Albertson
Journal:  Oncogene       Date:  2009-03-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.